Agendia

Recent Finacing

Equity

Recent Raise

$35M

Agendia develops and markets genomic-based cancer diagnostic tests—breast-cancer Symphony suite (MammaPrint, BluePrint, TargetPrint, TheraPrint), NGS/microarray platforms, companion-diagnostic collaborations and global sales/distribution.

Founded 2003

Noord-Holland, The Netherlands

101-250

Private

agendia.com

Highlights

Focus Areas

Biotechnology

Genetics

Health Care

Health Diagnostics

Life Science

Medical

Recent Investors

B

Financials

$143.9M

Total Raised

4

Funding rounds

8

Investors

Team

Upgrade to view the team

See the team members at Agendia.